» Articles » PMID: 37147524

Cardiovascular Manifestations of Turner Syndrome: Phenotypic Differences Between Karyotype Subtypes

Overview
Journal Pediatr Cardiol
Date 2023 May 5
PMID 37147524
Authors
Affiliations
Soon will be listed here.
Abstract

Turner syndrome (TS) is a genetic disorder presenting in phenotypic females with total or partial monosomy of the X chromosome. Cardiovascular abnormalities are common, including congenital heart defects (CHD) and aortic dilation. Although mosaic TS is suspected to have less severe phenotype as compared to non-mosaic TS, differences in cardiovascular manifestations between karyotypes are not well studied. This is a single-center retrospective cohort study including patients with TS seen from 2000 to 2022. Demographic data, chromosomal analysis, and imaging were reviewed. Karyotypes were categorized as monosomy X (45X), 45X mosaicism, isochromosome Xq, partial X deletions, ring X (r(X)), TS with Y material, and others. Prevalence of CHD and aortic dilation were compared between monosomy X and other subtypes using Pearson's chi-square test and Welch two-sample t-test. We included 182 TS patients with median age 18 (range 4-33) years. CHD was more common in monosomy X as compared with others (61.4% vs. 26.8%, p < 0.001), including bicuspid aortic valve (44.3% vs. 16.1%, p < 0.001), partial anomalous pulmonary venous return (12.9% vs. 2.7%, p = 0.023), persistent left superior vena cava (12.9% vs. 1.8%, p = 0.008), and coarctation of the aorta (20.0% vs. 4.5%, p = 0.003). Cardiac surgery (24.3% vs. 8.9%, p = 0.017) was more prevalent in the monosomy X group. There was no statistically significant difference for presence of aortic dilation (7.1% vs 1.8%, p = 0.187). Although CHD and need for cardiac surgery are more common in TS with monosomy X as compared to others, all TS subtypes may have similar risk of developing aortic dilation. All TS patients should have similar cardiovascular surveillance testing to monitor for aortic dilation.

Citing Articles

[Reflections on the clinical diagnosis and management of Turner syndrome].

Gu W, Zhao X Zhongguo Dang Dai Er Ke Za Zhi. 2024; 26(11):1135-1140.

PMID: 39587740 PMC: 11601105. DOI: 10.7499/j.issn.1008-8830.2407176.


Lifelong medical challenges and immunogenetics of Turner syndrome.

Cho W Clin Exp Pediatr. 2024; 67(11):560-568.

PMID: 39091155 PMC: 11551602. DOI: 10.3345/cep.2024.00430.


Are Young People with Turner Syndrome Who Have Undergone Treatment with Growth and Sex Hormones at Higher Risk of Metabolic Syndrome and Its Complications?.

Krzyscin M, Sowinska-Przepiera E, Gruca-Stryjak K, Soszka-Przepiera E, Syrenicz I, Przepiera A Biomedicines. 2024; 12(5).

PMID: 38790996 PMC: 11118016. DOI: 10.3390/biomedicines12051034.


Clinical practice guidelines for the care of girls and women with Turner syndrome.

Gravholt C, Andersen N, Christin-Maitre S, Davis S, Duijnhouwer A, Gawlik A Eur J Endocrinol. 2024; 190(6):G53-G151.

PMID: 38748847 PMC: 11759048. DOI: 10.1093/ejendo/lvae050.

References
1.
Bondy C . Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab. 2006; 92(1):10-25. DOI: 10.1210/jc.2006-1374. View

2.
McCarthy K, Bondy C . Turner syndrome in childhood and adolescence. Expert Rev Endocrinol Metab. 2009; 3(6):771-775. PMC: 2752892. DOI: 10.1586/17446651.3.6.771. View

3.
Duijnhouwer A, Bons L, Timmers H, van Kimmenade R, Snoeren M, Timmermans J . Aortic dilatation and outcome in women with Turner syndrome. Heart. 2018; 105(9):693-700. DOI: 10.1136/heartjnl-2018-313716. View

4.
Lopez L, Arheart K, Colan S, Stein N, Lopez-Mitnik G, Lin A . Turner syndrome is an independent risk factor for aortic dilation in the young. Pediatrics. 2008; 121(6):e1622-7. DOI: 10.1542/peds.2007-2807. View

5.
Gravholt C, Andersen N, Conway G, Dekkers O, Geffner M, Klein K . Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol. 2017; 177(3):G1-G70. DOI: 10.1530/EJE-17-0430. View